Roles of Mitochondrial Quality Control in the Pathogenesis of Atherosclerosis
Mitochondrial quality control (MQC) mechanisms – including biogenesis, dynamics, mitophagy, proteostasis, the unfolded protein response, and mitochondrial-derived vesicles – play critical roles in the development of atherosclerosis. Dysregulation of these processes can lead to mitochondrial dysfunct...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Compuscript Ltd
2025-03-01
|
| Series: | Cardiovascular Innovations and Applications |
| Online Access: | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2025.0013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850260396864176128 |
|---|---|
| author | Zakareya M. Alsalman Qiongjun Zhu Jiayi Hu Danan Wang Duanbin Li Wenbin Zhang |
| author_facet | Zakareya M. Alsalman Qiongjun Zhu Jiayi Hu Danan Wang Duanbin Li Wenbin Zhang |
| author_sort | Zakareya M. Alsalman |
| collection | DOAJ |
| description | Mitochondrial quality control (MQC) mechanisms – including biogenesis, dynamics, mitophagy, proteostasis, the unfolded protein response, and mitochondrial-derived vesicles – play critical roles in the development of atherosclerosis. Dysregulation of these processes can lead to mitochondrial dysfunction, and subsequently the initiation of a pathological cascade characterized by oxidative stress, chronic inflammation, and the accumulation of lipids within arterial walls. Specifically, ROS overproduction and redox state imbalance are key molecular aspects that exacerbate mitochondrial damage, and create a self-perpetuating cycle of cellular injury and disease progression. Emerging therapeutic strategies targeting the modulation of MQC have promise in attenuating atherosclerotic progression by restoring mitochondrial biogenesis, restoring the balance of fusion and fission dynamics, enhancing the clearance of damaged mitochondria, and improving protein homeostasis. Advancing understanding of the molecular regulators and protein interaction networks within MQC pathways might facilitate the development of precision-targeted therapies. However, substantial challenges persist in translating these insights into clinical applications. This review explores the relationship between MQC mechanisms and atherosclerosis, focusing on the associated pathways and potential avenues for therapeutic intervention. |
| format | Article |
| id | doaj-art-e81e91d228844bb686e8038216cde85d |
| institution | OA Journals |
| issn | 2009-8618 2009-8782 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Compuscript Ltd |
| record_format | Article |
| series | Cardiovascular Innovations and Applications |
| spelling | doaj-art-e81e91d228844bb686e8038216cde85d2025-08-20T01:55:39ZengCompuscript LtdCardiovascular Innovations and Applications2009-86182009-87822025-03-0110197010.15212/CVIA.2025.0013Roles of Mitochondrial Quality Control in the Pathogenesis of AtherosclerosisZakareya M. AlsalmanQiongjun ZhuJiayi HuDanan WangDuanbin LiWenbin ZhangMitochondrial quality control (MQC) mechanisms – including biogenesis, dynamics, mitophagy, proteostasis, the unfolded protein response, and mitochondrial-derived vesicles – play critical roles in the development of atherosclerosis. Dysregulation of these processes can lead to mitochondrial dysfunction, and subsequently the initiation of a pathological cascade characterized by oxidative stress, chronic inflammation, and the accumulation of lipids within arterial walls. Specifically, ROS overproduction and redox state imbalance are key molecular aspects that exacerbate mitochondrial damage, and create a self-perpetuating cycle of cellular injury and disease progression. Emerging therapeutic strategies targeting the modulation of MQC have promise in attenuating atherosclerotic progression by restoring mitochondrial biogenesis, restoring the balance of fusion and fission dynamics, enhancing the clearance of damaged mitochondria, and improving protein homeostasis. Advancing understanding of the molecular regulators and protein interaction networks within MQC pathways might facilitate the development of precision-targeted therapies. However, substantial challenges persist in translating these insights into clinical applications. This review explores the relationship between MQC mechanisms and atherosclerosis, focusing on the associated pathways and potential avenues for therapeutic intervention.https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2025.0013 |
| spellingShingle | Zakareya M. Alsalman Qiongjun Zhu Jiayi Hu Danan Wang Duanbin Li Wenbin Zhang Roles of Mitochondrial Quality Control in the Pathogenesis of Atherosclerosis Cardiovascular Innovations and Applications |
| title | Roles of Mitochondrial Quality Control in the Pathogenesis of Atherosclerosis |
| title_full | Roles of Mitochondrial Quality Control in the Pathogenesis of Atherosclerosis |
| title_fullStr | Roles of Mitochondrial Quality Control in the Pathogenesis of Atherosclerosis |
| title_full_unstemmed | Roles of Mitochondrial Quality Control in the Pathogenesis of Atherosclerosis |
| title_short | Roles of Mitochondrial Quality Control in the Pathogenesis of Atherosclerosis |
| title_sort | roles of mitochondrial quality control in the pathogenesis of atherosclerosis |
| url | https://www.scienceopen.com/hosted-document?doi=10.15212/CVIA.2025.0013 |
| work_keys_str_mv | AT zakareyamalsalman rolesofmitochondrialqualitycontrolinthepathogenesisofatherosclerosis AT qiongjunzhu rolesofmitochondrialqualitycontrolinthepathogenesisofatherosclerosis AT jiayihu rolesofmitochondrialqualitycontrolinthepathogenesisofatherosclerosis AT dananwang rolesofmitochondrialqualitycontrolinthepathogenesisofatherosclerosis AT duanbinli rolesofmitochondrialqualitycontrolinthepathogenesisofatherosclerosis AT wenbinzhang rolesofmitochondrialqualitycontrolinthepathogenesisofatherosclerosis |